135 related articles for article (PubMed ID: 11245668)
1. Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia nigra.
Hubert GW; Paquet M; Smith Y
J Neurosci; 2001 Mar; 21(6):1838-47. PubMed ID: 11245668
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural relationships between cortical, thalamic, and amygdala glutamatergic inputs and group I metabotropic glutamate receptors in the rat accumbens.
Mitrano DA; Pare JF; Smith Y
J Comp Neurol; 2010 Apr; 518(8):1315-29. PubMed ID: 20151362
[TBL] [Abstract][Full Text] [Related]
3. Subcellular and subsynaptic localization of presynaptic and postsynaptic kainate receptor subunits in the monkey striatum.
Kieval JZ; Hubert GW; Charara A; Paré JF; Smith Y
J Neurosci; 2001 Nov; 21(22):8746-57. PubMed ID: 11698586
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Group I Metabotropic Glutamate Receptors by MAPK/ERK in Neurons.
Mao LM; Wang JQ
J Nat Sci; 2016; 2(12):. PubMed ID: 28008418
[TBL] [Abstract][Full Text] [Related]
5. Effects of Hydrocodone Overdose and Ceftriaxone on Astrocytic Glutamate Transporters and Glutamate Receptors, and Associated Signaling in Nucleus Accumbens as well as Locomotor Activity in C57/BL Mice.
Wong W; Sari Y
Brain Sci; 2024 Apr; 14(4):. PubMed ID: 38672013
[TBL] [Abstract][Full Text] [Related]
6. Updates on the Physiopathology of Group I Metabotropic Glutamate Receptors (mGluRI)-Dependent Long-Term Depression.
Mango D; Ledonne A
Cells; 2023 Jun; 12(12):. PubMed ID: 37371058
[TBL] [Abstract][Full Text] [Related]
7. The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism.
Landucci E; Berlinguer-Palmini R; Baccini G; Boscia F; Gerace E; Mannaioni G; Pellegrini-Giampietro DE
Cells; 2022 Sep; 11(19):. PubMed ID: 36230976
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?
Budgett RF; Bakker G; Sergeev E; Bennett KA; Bradley SJ
Front Pharmacol; 2022; 13():893422. PubMed ID: 35645791
[TBL] [Abstract][Full Text] [Related]
9. Group I mGluRs in Therapy and Diagnosis of Parkinson's Disease: Focus on mGluR5 Subtype.
Azam S; Jakaria M; Kim J; Ahn J; Kim IS; Choi DK
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453614
[TBL] [Abstract][Full Text] [Related]
10. Altered Expression and
Matrisciano F; Locci V; Dong E; Nicoletti F; Guidotti A; Grayson DR
Curr Neuropharmacol; 2022 Nov; 20(12):2354-2368. PubMed ID: 35139800
[TBL] [Abstract][Full Text] [Related]
11. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective.
Su LD; Wang N; Han J; Shen Y
Neuroscientist; 2022 Oct; 28(5):453-468. PubMed ID: 34088252
[TBL] [Abstract][Full Text] [Related]
12. Activity-dependent somatodendritic dopamine release in the substantia nigra autoinhibits the releasing neuron.
Hikima T; Lee CR; Witkovsky P; Chesler J; Ichtchenko K; Rice ME
Cell Rep; 2021 Apr; 35(1):108951. PubMed ID: 33826884
[TBL] [Abstract][Full Text] [Related]
13. Effects of 3-Month Exposure to E-Cigarette Aerosols on Glutamatergic Receptors and Transporters in Mesolimbic Brain Regions of Female C57BL/6 Mice.
Alhaddad H; Wong W; Sari AT; Crotty Alexander LE; Sari Y
Toxics; 2020 Oct; 8(4):. PubMed ID: 33137879
[TBL] [Abstract][Full Text] [Related]
14. Location and Cell-Type-Specific Bias of Metabotropic Glutamate Receptor, mGlu
Jong YI; Harmon SK; O'Malley KL
ACS Chem Neurosci; 2019 Nov; 10(11):4558-4570. PubMed ID: 31609579
[TBL] [Abstract][Full Text] [Related]
15. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects.
Albarrán-Bravo S; Ávalos-Fuentes JA; Cortés H; Rodriguez-Sánchez M; Leyva-García N; Rangel-Barajas C; Erlij D; Florán B
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480516
[TBL] [Abstract][Full Text] [Related]
16. The neurobiological basis for novel experimental therapeutics in dystonia.
Downs AM; Roman KM; Campbell SA; Pisani A; Hess EJ; Bonsi P
Neurobiol Dis; 2019 Oct; 130():104526. PubMed ID: 31279827
[TBL] [Abstract][Full Text] [Related]
17. Role of Metabotropic Glutamate Receptors in Neurological Disorders.
Crupi R; Impellizzeri D; Cuzzocrea S
Front Mol Neurosci; 2019; 12():20. PubMed ID: 30800054
[TBL] [Abstract][Full Text] [Related]
18. mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB Signaling.
Ledonne A; Mercuri NB
Front Mol Neurosci; 2018; 11():346. PubMed ID: 30327588
[TBL] [Abstract][Full Text] [Related]
19. Intracellular GPCRs Play Key Roles in Synaptic Plasticity.
Jong YI; Harmon SK; O'Malley KL
ACS Chem Neurosci; 2018 Sep; 9(9):2162-2172. PubMed ID: 29409317
[TBL] [Abstract][Full Text] [Related]
20. Sustained Activity of Metabotropic Glutamate Receptor: Homer, Arrestin, and Beyond.
Chung G; Kim SJ
Neural Plast; 2017; 2017():5125624. PubMed ID: 29359050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
